The concept behind BCR::ABL1 positive CML treatment strategy and TKD mutation.
Chronic myeloid leukaemia (CML), a malignant disease derived from a haematopoietic stem cell clone, CML arises from the t(9;22)(q34;q11) balanced reciprocal translocation between chromosome 9 and 22 that forms the Philadelphia chromosome. The translocation event…
